在前列腺癌治疗后利用失禁程序:人口层面的分析
Ryan Davis1, David Ginsberg1, Jeffrey C Loh-Doyle1
1Department of Urology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
Neurourology and urodynamics
|August 5, 2025
概括
人工尿道 (AUS) 和尿道用于前列腺癌治疗后的失禁. 使用情况因患者因素而异,突出显示了对指导方针意识的必要性.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 医疗器械的利用 医疗器械的利用
背景情况:
- 在前列腺癌治疗后,尿失禁很常见,例如激进前列腺切除术 (RP) 和放射治疗 (RT).
- 人工尿道关节 (AUS) 和尿道可以治疗压力失禁,但它们在治疗后的使用尚未明确定义.
研究的目的:
- 评估在接受RP和/或RT治疗的患者中AUS和尿道链手术的利用率.
- 为了确定与使用这些失禁程序相关的患者因素.
主要方法:
- 在2005-2015年间使用TrinetX数据库对18岁以上接受RP或RT治疗的男性进行了回顾性分析.
- 排除在前前列腺癌治疗之前有AUS或吊链植入的患者.
- 主要结局:治疗后6个月至10年的AUS和吊带利用率;次要结局:囊囊甲透镜率和相关的患者因素.
主要成果:
- 观察到的使用率较低:RP后 (AUS 1.82%,摇摆1.75%),RT后 (AUS 0.35%,摇摆0.05%). 在使用率较低的情况下,使用率较低.
- 在接受RP和RT治疗的患者中,利用率更高 (AUS3.70%,sling1.10%).
- 与更高利用率相关的因素包括RP,学术中心护理和45-69岁. 种族/种族也影响了利用.
结论:
- 在前列腺癌治疗 (RP/RT) 后,用于治疗失禁的AUS和尿道的利用率很低.
- 基于患者的特征,程序使用存在显著差异.
- 强调需要更好地了解已建立的指导方针,以管理前列腺切除术后的失禁.
相关概念视频
Nursing Assessment of the Genitourinary System I: Health History
77
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
77
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
38
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
38
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455


